{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:26:52Z","timestamp":1770233212623,"version":"3.49.0"},"reference-count":22,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"DOI":"10.2337\/dci19-0030","type":"journal-article","created":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T00:25:31Z","timestamp":1569025531000},"page":"1842-1844","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":26,"title":["Progression of Diabetic Kidney Disease in the Absence of Albuminuria"],"prefix":"10.2337","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8058-6977","authenticated-orcid":false,"given":"Richard J.","family":"MacIsaac","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, St Vincent's Hospital, and University of Melbourne, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2372-395X","authenticated-orcid":false,"given":"Elif I.","family":"Ekinci","sequence":"additional","affiliation":[{"name":"Austin Health and Department of Medicine, University of Melbourne, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"key":"2022031221120147600_B1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/diab.41.5.581","article-title":"Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion","volume":"41","author":"Lane","year":"1992","journal-title":"Diabetes"},{"key":"2022031221120147600_B2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diab.43.5.649","article-title":"Progressive decline in renal function in diabetic patients with and without albuminuria","volume":"43","author":"Tsalamandris","year":"1994","journal-title":"Diabetes"},{"key":"2022031221120147600_B3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diab.32.2.S64","article-title":"The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy","volume":"32","author":"Mogensen","year":"1983","journal-title":"Diabetes"},{"key":"2022031221120147600_B4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MNH.0b013e3283456546","article-title":"Diabetic kidney disease with and without albuminuria","volume":"20","author":"Macisaac","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2022031221120147600_B5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jdiacomp.2012.10.010","article-title":"Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population","volume":"27","author":"Afghahi","year":"2013","journal-title":"J Diabetes Complications"},{"key":"2022031221120147600_B6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S2213-8587(15)00094-7","article-title":"Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes","volume":"3","author":"Porrini","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031221120147600_B7","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/dc09-1098","article-title":"Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study","volume":"33","author":"Molitch","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031221120147600_B8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s00125-017-4251-1","article-title":"Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus","volume":"60","author":"Penno","year":"2017","journal-title":"Diabetologia"},{"key":"2022031221120147600_B9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ndt\/gfq526","article-title":"The use of eGFR and ACR to predict decline in renal function in people with diabetes","volume":"26","author":"Hoefield","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2022031221120147600_B10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.ajkd.2018.02.364","article-title":"Risk of progression of nonalbuminuric CKD to end-stage kidney disease in people with diabetes: the\u00a0CRIC (Chronic Renal Insufficiency Cohort) Study","volume":"72","author":"Koye","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2022031221120147600_B11","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.2337\/dc19-0349","article-title":"Progressive decline in estimated glomerular filtration rate in patients with diabetes after moderate loss in kidney function\u2014even without albuminuria","volume":"42","author":"Vistisen","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031221120147600_B12","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2337\/dc05-1788","article-title":"Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?","volume":"29","author":"MacIsaac","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031221120147600_B13","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.2337\/dc12-2572","article-title":"Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function","volume":"36","author":"Ekinci","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031221120147600_B14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2337\/dc18-1320","article-title":"Nonproteinuric versus proteinuric phenotypes in diabetic kidney disease: a propensity score\u2013matched analysis of a nationwide, biopsy-based cohort study","volume":"42","author":"Yamanouchi","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031221120147600_B15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diabetes.52.4.1036","article-title":"Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions","volume":"52","author":"Caramori","year":"2003","journal-title":"Diabetes"},{"key":"2022031221120147600_B16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"2022031221120147600_B17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(18)30141-4","article-title":"Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials","volume":"6","author":"Perkovic","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031221120147600_B18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S2213-8587(19)30180-9","article-title":"Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial","volume":"7","author":"Mosenzon","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031221120147600_B19","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.kint.2016.10.046","article-title":"Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes","volume":"91","author":"Krolewski","year":"2017","journal-title":"Kidney Int"},{"key":"2022031221120147600_B20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.diabres.2018.04.026","article-title":"Clinical predictive biomarkers for normoalbuminuric diabetic kidney disease","volume":"141","author":"Gohda","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031221120147600_B21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MNH.0000000000000489","article-title":"Nonproteinuric progressive diabetic kidney disease","volume":"28","author":"Zoccali","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2022031221120147600_B22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41591-019-0415-5","article-title":"A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes","volume":"25","author":"Niewczas","year":"2019","journal-title":"Nat Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/10\/1842\/528083\/dci190030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/10\/1842\/528083\/dci190030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:14:35Z","timestamp":1647126875000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/10\/1842\/30618\/Progression-of-Diabetic-Kidney-Disease-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,9,12]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci19-0030","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]}}}